LASTACAFT (Page 2 of 2)

17.3 Topical Ophthalmic Use only

For topical ophthalmic administration only.

Manufactured for Allergan, Inc., Irvine, CA 92612, U.S.A.
© 2010 Allergan, Inc.
® and ™ marks owned by Allergan, Inc.
Manufactured in the U.S.A. by JHP Pharmaceuticals, LLC


Relabeling and Repackaging by:
Physicians Total Care, Inc., Tulsa, OK 74146

NDC 54868-6294-0

image of package label


(alcaftadine ophthalmic

solution) 0.25%

3 mL Sterile

alcaftadine solution/ drops
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:54868-6294(NDC:0023-4290)
Route of Administration OPHTHALMIC DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
alcaftadine (alcaftadine) alcaftadine 2.5 mg in 1 mL
Inactive Ingredients
Ingredient Name Strength
benzalkonium chloride
edetate disodium
sodium phosphate, monobasic
sodium chloride
sodium hydroxide
hydrochloric acid
# Item Code Package Description Multilevel Packaging
1 NDC:54868-6294-0 1 BOTTLE, PLASTIC (1 BOTTLE) in 1 CARTON contains a BOTTLE, PLASTIC
1 3 mL in 1 BOTTLE, PLASTIC This package is contained within the CARTON (54868-6294-0)
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
NDA NDA022134 08/19/2011
Labeler — Physicians Total Care, Inc. (194123980)
Name Address ID/FEI Operations
Physicians Total Care, Inc. 194123980 relabel, repack

Revised: 09/2010 Physicians Total Care, Inc.

Page 2 of 2 1 2

All resources are included in as near-original form as possible, meaning that the information from the original provider has been rendered here with only typographical or stylistic modifications and not with any substantive alterations of content, meaning or intent.

This site is provided for educational and informational purposes only, in accordance with our Terms of Use, and is not intended as a substitute for the advice of a medical doctor, nurse, nurse practitioner or other qualified health professional.

Privacy Policy | Copyright © 2021. All Rights Reserved.